Jia Baolei, Jeon Che Ok
Department of Life Science, Chung-Ang University, Seoul 06974, Republic of Korea
Open Biol. 2016 Aug;6(8). doi: 10.1098/rsob.160196.
The ease of genetic manipulation, low cost, rapid growth and number of previous studies have made Escherichia coli one of the most widely used microorganism species for producing recombinant proteins. In this post-genomic era, challenges remain to rapidly express and purify large numbers of proteins for academic and commercial purposes in a high-throughput manner. In this review, we describe several state-of-the-art approaches that are suitable for the cloning, expression and purification, conducted in parallel, of numerous molecules, and we discuss recent progress related to soluble protein expression, mRNA folding, fusion tags, post-translational modification and production of membrane proteins. Moreover, we address the ongoing efforts to overcome various challenges faced in protein expression in E. coli, which could lead to an improvement of the current system from trial and error to a predictable and rational design.
基因操作简便、成本低、生长迅速以及已有大量研究,使得大肠杆菌成为生产重组蛋白时使用最为广泛的微生物物种之一。在这个后基因组时代,如何以高通量方式为学术和商业目的快速表达和纯化大量蛋白质仍然面临挑战。在本综述中,我们描述了几种适用于同时平行进行众多分子的克隆、表达和纯化的先进方法,并讨论了与可溶性蛋白表达、mRNA折叠、融合标签、翻译后修饰以及膜蛋白生产相关的最新进展。此外,我们还阐述了为克服大肠杆菌蛋白表达中面临的各种挑战而正在进行的努力,这些努力可能会使当前系统从反复试验改进为可预测的合理设计。